Post by Rebrain.

2,795 followers

š—˜š—®š—°š—µ š—Æš—æš—®š—¶š—» š—¶š˜€ š˜‚š—»š—¶š—¾š˜‚š—². š—”š˜€ š—® š—æš—²š˜€š˜‚š—¹š˜, š˜š—®š—æš—“š—²š˜š—¶š—»š—“ š—±š—²š—°š—¶š˜€š—¶š—¼š—»š˜€ š—ŗš˜‚š˜€š˜ š—Æš—² š—½š—æš—²š—°š—¶š˜€š—², š—æš—²š—½š—æš—¼š—±š˜‚š—°š—¶š—Æš—¹š—², š—®š—»š—± š˜š—®š—¶š—¹š—¼š—æš—²š—± š˜š—¼ š—²š—®š—°š—µ š—½š—®š˜š—¶š—²š—»š˜. This is exactly the challenge addressed by David Caumartin, CEO of Rebrain, in this interview given to mieux during SantExpo 2026. If you are interested in functional neurosurgery, clinical data, or the future of medicine, this discussion is worth a few minutes of your time. šŸŽ„ Watch his intervention (from 08:25 to 15:40) in the video below: https://lnkd.in/ea9xkcQJ Many thanks to the mieux team for this invitation and for this insightful exchange! #Santexpo2026

Post content